This module focuses on how generic drugs are approved and what drives drug pricing.
OBJECTIVES FOR LEARNING OUTCOMES
At the conclusion of this activity, participants will be better able to:
- Describe how a drug is licensed, what the difference is between an NDA and an ANDA, and the
intellectual property considerations that underlie the distinction.
- Enumerate the key players (PBMs, pharamceutical companies, regulators, etc.) that affect drug
- Propose regulatory frameworks that would make prescription medications more accessible.
Presentation & Handout
Dan Leifer, MD
Resident Physician in Dermatology and Board-Certified Pediatrician, Division of Dermatology, UW
Generic Drugs and Drug Pricing